Flex Pharma (FLKS) Misses Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts FLKS Hot Sheet
Join SI Premium – FREE
Flex Pharma (NASDAQ: FLKS) reported Q2 EPS of ($0.47), $0.10 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Flex Pharma (FLKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- VIST Financial Corp. (VIST) Misses Q1 EPS by 19c
- Methanex (MEOH) Tops Q1 EPS by 35c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
